Franceschelli, J. J., Belardinelli, J. M., Tong, P., Loftus, B., Recio Balsells, A. I., Labadie, G. R., . . . Morbidoni, H. R. (2018). A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide. Web
Citación estilo ChicagoFranceschelli, Jorgelina Judith, Juan Manuel Belardinelli, Ping Tong, Brendan Loftus, Alejandro Iván Recio Balsells, Guillermo Roberto Labadie, Stephen V. Gordon, and Héctor Ricardo Morbidoni. A KatG S315T or an AhpC Promoter Mutation Mediate Mycobacterium Tuberculosis Resistance to 2-thiophen Carboxylic Acid Hydrazide, an Inhibitor Resembling the Anti-tubercular Drugs Isoniazid and Ethionamide. 2018.
Cita MLAFranceschelli, Jorgelina Judith, et al. A KatG S315T or an AhpC Promoter Mutation Mediate Mycobacterium Tuberculosis Resistance to 2-thiophen Carboxylic Acid Hydrazide, an Inhibitor Resembling the Anti-tubercular Drugs Isoniazid and Ethionamide. 2018.